2.Overview research of uremic ulearance granule treating chronic renal failure.
Xian-Jie MENG ; Yi-Gang WAN ; Qing-Xue WEI ; Hao-Li CHEN ; Xi-Miao SHI ; Yan-Ru HUANG ; Jian YAO
China Journal of Chinese Materia Medica 2013;38(21):3651-3655
The effective bioactivity compositions of uremic clearance granul (UCG) include isoflavonoids, emodin, astragaloside, paeoniflorin, salvianolic acid A, and so on. The effects of UCG treating chronic renal failure (CRF) in clinical pharmacodynamics mainly refer to improve renal function and the complications of CRF. The mechanisms involved in vivo basically include depressing transforming growth factor (TGF)-beta1 over-expression, lessening podocyte injury,inhibiting tubular epithelial myofibroblast transdifferentiation, ameliorating microinflammation status, retarding oxidative stress, and alleviating insulin resistance.
Animals
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
Kidney
;
drug effects
;
metabolism
;
Kidney Failure, Chronic
;
drug therapy
;
genetics
;
metabolism
;
Oxidative Stress
;
drug effects
;
Transforming Growth Factor beta1
;
genetics
;
metabolism
3.Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies.
Soo Heon KWAK ; Kyong Soo PARK
Endocrinology and Metabolism 2015;30(2):147-158
Diabetes is a common metabolic disorder with a worldwide prevalence of 8.3% and is the leading cause of visual loss, end-stage renal disease and amputation. Recently, genome-wide association studies (GWASs) have identified genetic risk factors for diabetic microvascular complications of retinopathy, nephropathy, and neuropathy. We summarized the recent findings of GWASs on diabetic microvascular complications and highlighted the challenges and our opinion on future directives. Five GWASs were conducted on diabetic retinopathy, nine on nephropathy, and one on neuropathic pain. The majority of recent GWASs were underpowered and heterogeneous in terms of study design, inclusion criteria and phenotype definition. Therefore, few reached the genome-wide significance threshold and the findings were inconsistent across the studies. Recent GWASs provided novel information on genetic risk factors and the possible pathophysiology of diabetic microvascular complications. However, further collaborative efforts to standardize phenotype definition and increase sample size are necessary for successful genetic studies on diabetic microvascular complications.
Amputation
;
Diabetic Retinopathy
;
Genetics
;
Genome-Wide Association Study*
;
Kidney Failure, Chronic
;
Neuralgia
;
Phenotype
;
Prevalence
;
Risk Factors
;
Sample Size
4.MTHFR C677T Polymorphism as a Risk Factor for Vascular Calcification in Chronic Hemodialysis Patients.
So Young LEE ; Hoe Young KIM ; Kyung Mi PARK ; Stephen Yon LEE ; Seong Geun HONG ; Hyung Jong KIM ; Dong Ho YANG
Journal of Korean Medical Science 2011;26(3):461-465
Polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T is one of the suggested risk factors for atherosclerosis. However, few studies have reported on the relationship between MTHFR C677T polymorphism and vascular calcification (VC) in chronic hemodialysis patients. We investigated the relationship between the MTHFR C677T polymorphism and VC in 152 chronic hemodialysis patients. Patients with a TT genotype exhibited significantly higher VC scores than patients expressing CC and CT (P = 0.002). The prevalence of peripheral vascular disease increased with the incidence of MTHFR C677T mutations for all patients, and the incidence of cerebrovascular accidents also increased with the presence of mutations for young patients (< or = 60 yr) (P < 0.05). Patients with CT and TT genotypes had adjusted odds ratios for VC of 1.39 and 1.58, respectively (P < 0.05). In summary, these data suggest that the MTHFR C677T polymorphism affects the degree of VC in chronic hemodialysis patients.
Aged
;
Calcinosis/*genetics
;
Genetic Predisposition to Disease
;
Humans
;
Kidney Failure, Chronic/*genetics
;
Methylenetetrahydrofolate Reductase (NADPH2)/*genetics
;
Middle Aged
;
*Polymorphism, Single Nucleotide
;
*Renal Dialysis
;
Risk Factors
;
Vascular Diseases/*genetics
5.Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Kyu Beck LEE ; Un Kyung KIM ; Chung Choo LEE
Journal of Korean Medical Science 2000;15(4):431-435
Renin-angiotensin system is considered important in the genesis of hypertension and development of end-stage renal disease (ESRD) in autosomal dominant polycystic kidney disease (ADPKD). The angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism has been associated with susceptibility to the development of some renal diseases. We investigated the association of ACE gene polymorphism with the progression to hypertension and ESRD in 108 patients with ADPKD. The ACE I/D polymorphism was amplified with the flanking primers by polymerase chain reaction. In patients genotyped for ACE gene polymorphism, the frequencies of DD (15+ACU-), ID (51+ACU-) and II (34+ACU-) genotypes were similar to those of the general population. Of the 108 patients, 64 (59+ACU-) developed hypertension and 24 (22+ACU-) reached ESRD at the time of study. The prevalence of hypertension was not significantly different among the three genotypes. The mean renal survival time was 53-6 yr in II genotype, 5510 yr in ID genotype and 529 yr in DD genotype which was not significantly different among them. Cumulative renal survival was not significantly different either. There was no association of ACE gene polymorphism with the prevalence of hypertension and renal survival in ADPKD. We suggest that ACE I/D polymorphism is not an important modifying gene in the progression of ADPKD.
Adult
;
Aged
;
Comparative Study
;
Disease Progression
;
Female
;
Genetic Predisposition to Disease
;
Genotype
;
Human
;
Hypertension, Renal/etiology
;
Hypertension, Renal/epidemiology
;
Kidney Failure, Chronic/etiology
;
Kidney Failure, Chronic/epidemiology
;
Korea/epidemiology
;
Male
;
Middle Age
;
Peptidyl-Dipeptidase A/genetics+ACo-
;
Polycystic Kidney, Autosomal Dominant/genetics+ACo-
;
Polycystic Kidney, Autosomal Dominant/epidemiology
;
Polycystic Kidney, Autosomal Dominant/enzymology
;
Polycystic Kidney, Autosomal Dominant/complications
;
Polymerase Chain Reaction
;
Polymorphism (Genetics)+ACo-
;
Prevalence
6.Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Kyu Beck LEE ; Un Kyung KIM ; Chung Choo LEE
Journal of Korean Medical Science 2000;15(4):431-435
Renin-angiotensin system is considered important in the genesis of hypertension and development of end-stage renal disease (ESRD) in autosomal dominant polycystic kidney disease (ADPKD). The angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism has been associated with susceptibility to the development of some renal diseases. We investigated the association of ACE gene polymorphism with the progression to hypertension and ESRD in 108 patients with ADPKD. The ACE I/D polymorphism was amplified with the flanking primers by polymerase chain reaction. In patients genotyped for ACE gene polymorphism, the frequencies of DD (15+ACU-), ID (51+ACU-) and II (34+ACU-) genotypes were similar to those of the general population. Of the 108 patients, 64 (59+ACU-) developed hypertension and 24 (22+ACU-) reached ESRD at the time of study. The prevalence of hypertension was not significantly different among the three genotypes. The mean renal survival time was 53-6 yr in II genotype, 5510 yr in ID genotype and 529 yr in DD genotype which was not significantly different among them. Cumulative renal survival was not significantly different either. There was no association of ACE gene polymorphism with the prevalence of hypertension and renal survival in ADPKD. We suggest that ACE I/D polymorphism is not an important modifying gene in the progression of ADPKD.
Adult
;
Aged
;
Comparative Study
;
Disease Progression
;
Female
;
Genetic Predisposition to Disease
;
Genotype
;
Human
;
Hypertension, Renal/etiology
;
Hypertension, Renal/epidemiology
;
Kidney Failure, Chronic/etiology
;
Kidney Failure, Chronic/epidemiology
;
Korea/epidemiology
;
Male
;
Middle Age
;
Peptidyl-Dipeptidase A/genetics+ACo-
;
Polycystic Kidney, Autosomal Dominant/genetics+ACo-
;
Polycystic Kidney, Autosomal Dominant/epidemiology
;
Polycystic Kidney, Autosomal Dominant/enzymology
;
Polycystic Kidney, Autosomal Dominant/complications
;
Polymerase Chain Reaction
;
Polymorphism (Genetics)+ACo-
;
Prevalence
7.Expression of ghrelin and its receptor GHS-R in the hypothalamus and gastrointestinal tract in rats with chronic renal failure.
Rong-guo FU ; Hao-zheng YUAN ; Li WANG ; Heng GE ; Jun ZHANG ; Qi-lan NING ; Fu-jun ZHANG
Journal of Southern Medical University 2011;31(1):96-99
OBJECTIVETo investigate the expression of ghrelin and its receptor, growth hormone secretagogue receptor (GHS-R), in the hypothalamus and gastrointestinal tract in rats with chronic renal failure (CRF) and explore their relationship with the disorder of gastrointestinal tract motility.
METHODSSD rats were randomly divided into sham-operated group (n=8) and CRF group (n=16), and in the latter group, the rats were subjected to 5/6 nephrectomy to induce CRF. Real-time PCR and immunohistochemical staining were used to detect the distribution of mRNA and protein of ghrelin and GHS-R in the gastric fundus, duodenum, and hypothalamus.
RESULTSThe rats in the CRF group showed a significantly higher expression of ghrelin mRNA and protein in the gastric fundus but a lower expression in the hypothalamus than those in the sham-operated group (P<0.01), but the expression in the duodenum was similar between the two groups (P>0.05). The expression of GHS-R mRNA and protein in the gastric fundus was significantly higher in the CRF group than in the sham-operated group (P<0.01), while in the hypothalamus and duodenum, the expression was significantly lower in the CRF group (P<0.01).
CONCLUSIONThe different distribution patterns of ghrelin and GHS-R in the tissues may be an important pathological basis of gastrointestinal motility disorder in CRF.
Animals ; Gastrointestinal Tract ; metabolism ; Ghrelin ; genetics ; metabolism ; Hypothalamus ; metabolism ; Kidney Failure, Chronic ; metabolism ; Male ; RNA, Messenger ; genetics ; metabolism ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptors, Ghrelin ; genetics ; metabolism
8.Interleukin-10 genotype protects end stage renal disease patients from microinflammation and arteriosclerosis.
Hong-chi WU ; Hong LING ; Shi-ping NA ; Ru-juan XIE
Chinese Medical Journal 2005;118(18):1549-1551
Adult
;
Aged
;
Arteriosclerosis
;
epidemiology
;
prevention & control
;
Female
;
Genotype
;
Humans
;
Incidence
;
Inflammation
;
epidemiology
;
prevention & control
;
Interleukin-10
;
blood
;
genetics
;
Kidney Failure, Chronic
;
complications
;
genetics
;
Male
;
Middle Aged
;
Polymorphism, Genetic
9.Clinical and genetic features of X-linked Alport syndrome in men positive for the collagen Ⅳ α5 chain in epidermal basement membrane.
Yanqin ZHANG ; Jie DING ; Fang WANG ; Hongwen ZHANG ; Huijie XIAO ; Yong YAO ; Xuhui ZHONG ; Na GUAN ; Xiaoyu LIU ; Lixia YU ; Jingcheng LIU ; Jiyun YANG
Chinese Journal of Pediatrics 2016;54(1):61-64
OBJECTIVETo analyze the clinical and genetic features of X-linked Alport syndrome (XLAS) in men positive for the collagen α5(Ⅳ) chain in epidermal basement membrane.
METHODThis was a retrospective study. Totally 725 families were diagnosed as Alport syndrome in Department of Pediatrics of Peking University First Hospital during January 1998 to December 2014, among them 450 patients were males with XLAS. Patients who met both of the following two criteria were included in this study. (1)Patients underwent α5(Ⅳ) chain staining in the epidermal basement membrane. (2)Mutations in COL4A5 gene were detected.Mann-Whitney test and χ(2) test were used.
RESULTTotally 140 males with XLAS were included in this study, 18 cases were α5 (Ⅳ)-positive and 122 cases were α5 (Ⅳ)-negative. The two groups of patients were compared, the median age at analysis was 11.0 vs. 7.2 years (Z = -1.839, P = 0.066), the 24-hour urine protein was 1.50 vs. 0.57 g/d (Z = -1.212, P = 0.226), the rate of hearing loss was 28% vs. 53% (χ(2) = 3.619, P = 0.067), the number of patients progressed to end stage renal disease (ESRD) was 4 vs. 12 (χ(2) =2.377, P = 0.128), the median age of ESRD was 31.0 vs. 16.6 years (Z = -2.554, P = 0.011), the rate of missense mutations in COL4A5 gene was 67% vs. 52% (χ(2) = 1.424, P = 0.313).
CONCLUSIONCompared the two groups of patients with positive and negative staining for the collagen Ⅳ α5 chain in epidermal basement membrane, there was no significant difference in the proteinuria level, the rate of hearing loss and genotype of COL4A5 gene. But the patients with positive staining progressed to ESRD significantly later than the patients with negative staining.
Basement Membrane ; pathology ; Child ; Collagen Type IV ; genetics ; DNA Mutational Analysis ; Deafness ; Humans ; Kidney Failure, Chronic ; Male ; Mutation, Missense ; Nephritis, Hereditary ; genetics ; pathology ; Proteinuria ; Retrospective Studies
10.Angiotensinogen and Angiotensin II Type 1 Receptor Gene Polymorphism in Patients with Autosomal Dominant Polycystic Kidney Disease: Effect on Hypertension and ESRD.
Yonsei Medical Journal 2003;44(4):641-647
Autosomal dominant polycystic kidney disease (ADPKD), a common genetic disease, is characterized by the development of hypertension and end stage renal disease. An increase in the activity of the renin-angiotensin system, due to a renal ischemia caused by cyst expansion, contributes to the development of hypertension and renal failure in ADPKD. Recently, the angiotensinogen (AGT) gene, M235T, and angiotensin II type 1 receptor (ATR) gene, A1166C, polymorphisms have been associated with the susceptibility to develop hypertension and renal disease. We hypothesized that the AGT M235T and ATR A1166C polymorphisms could account for some of the variability in the progression of ADPKD. Genotyping was performed in 108 adult patients with ADPKD, and 105 normotensive healthy controls, using PCR and restriction digestion. We analyzed the effects of the AGT M235T and ATR A1166C polymorphisms on hypertension and age at the end stage renal disease (ESRD). Of the 108 patients with ADPKD, 64 (59%) had hypertension and 24 (22%) reached the ESRD. The prevalence of hypertension were; [MM+MT], [TT] genotypes, 60%, 59% (p=1.00) ; [AA], [AC+CC] genotypes, 60%, 50% respectively (p=0.54). The ages at the onset of ESRD were; [MM+MT], [TT] genotypes, 50 +/- 9 years, 56 +/- 8 years (p=0.07) ; [AA], [AC+CC] genotypes, 54 +/- 8 years, 52 +/- 14 years, respectively (p=0.07). There were no differences in the prevalence of hypertension and the ages at the ESRD in relation to the AGT M235T and ATR A1166C polymorphisms. We suggest that the AGT and ATR gene polymorphisms would not have an effect on hypertension or the ESRD in ADPKD.
Adult
;
Age of Onset
;
Angiotensinogen/*genetics
;
Disease Progression
;
Female
;
Human
;
Hypertension/epidemiology/etiology
;
Kidney Failure, Chronic/epidemiology/etiology
;
Male
;
Middle Aged
;
Polycystic Kidney, Autosomal Dominant/complications/*genetics/physiopathology
;
Polymorphism (Genetics)
;
Prevalence
;
Receptor, Angiotensin, Type 1
;
Receptors, Angiotensin/*genetics